| ACD | absolute cardiac dullness; absolute claudication distance; acid-citrate-dextrose [solution]; actinom... |
|---|---|
| CPD | calcium pyrophosphate deposition; cephalopelvic disproportion; cerebelloparenchymal disorder; childh... |
| CPDA | citrate-phosphate-dextrose-adenine |
| PCD | pacer-cardioverter-defibrillator; papillary collecting duct; paraneoplastic cerebellar degeneration;... |
| SSC | single-strand conformational [analysis]; sister strand crossover; somatosensory cortex; standard sal... |
| CPD | Citrate-phosphate-dextrose |
|---|---|
| CPDA-1 | Citrate-phosphate-dextrose-adenine |
| ACD | Acid citrate dextrose |
| PDA | Potato Dextrose Agar |
| SDA | Sabouraud Dextrose Agar |
| acid-citrate-dextrose | A citrate anticoagulant used for the collection and preservation of whole blood. It has largely been replaced by newer coagulants (CPD, Adsol) that allow for longer shelf life for blood and blood products. Acronym: ACD (05 Mar 2000) |
|---|---|
| anticoagulant | <haematology, pharmacology> Any substance that prevents blood clotting. Those drugs administered for prophylaxis or treatment of thromboembolic disorders are heparin, which inactivates thrombin and several other clotting factors and which must be administered parenterally and the oral anticoagulants (warfarin, dicumarol and congeners) which inhibit the hepatic synthesis of vitamin K dependent clotting factors. Anticoagulant solutions used for the preservation of stored whole blood and blood fractions are acid citrate dextrose (ACD), citrate phosphate dextrose (CPD), citrate phosphate dextrose adenine (cPDA 1) and heparin. Anticoagulants used to prevent clotting of blood specimens for laboratory analysis are heparin and several substances that make calcium ions unavailable to the clotting process, including EDTA (ethylenediaminetetraacetic acid), citrate, oxalate and fluoride. (18 Nov 1997) |
| anticoagulant therapy | The use of anticoagulant drugs to reduce or prevent intravascular or intracardiac clotting. (05 Mar 2000) |
| vascular anticoagulant | <protein> Group of calcium-binding proteins that interact with acidic membrane phospholipids in membranes. They contain 4 or 8 repeats of a 61 amino acid domain that folds into 5 a helices. Also known by several other names (e.g. Lipocortins, endonexins), reflecting the history of their discovery in different contexts. See: lipocortin, endonexin I & II, calpactin, p70 and calelectrin. (18 Nov 1997) |
| potato dextrose agar | A culture medium used extensively for the cultivation of fungi; especially good for development of conidia and other sporulating forms by which an organism is identified microscopically. (05 Mar 2000) |
| Sabouraud's dextrose agar | A dextrose peptone media that supports the growth of most pathogenic fungi. (05 Mar 2000) |
| dextrose | <chemistry> A sirupy, or white crystalline, variety of sugar, C6H12O6 (so called from turning the plane of polarization to the right), occurring in many ripe fruits. Dextrose and levulose are obtained by the inversion of cane sugar or sucrose, and hence called invert sugar. Dextrose is chiefly obtained by the action of heat and acids on starch, and hence called also starch sugar. It is also formed from starchy food by the action of the amylolytic ferments of saliva and pancreatic juice. The solid products are known to the trade as grape sugar; the sirupy products as glucose, or mixing sirup. These are harmless, but are only about half as sweet as cane or sucrose. See: Dexter. Source: Websters Dictionary (01 Mar 1998) |
| lupus anticoagulant | An immunoglobulin that interferes with blood coagulation and has antithromboplastin activity. This immunoglobulin can prolong blood clotting and occurs in approximately 25% of people with lupus. (27 Sep 1997) |
| UDPacetylglucosamine-dolichyl-phosphate acetylglucosamine-1-phosphate transferase | <enzyme> Transfers n-acetylglucosamine 1-phosphate from udp-n-acetylglucosamine to dolichyl phosphate, forming n-acetylglucosaminylpyrophosphoryldolichol Chemical name: udp-glcnac-dolichyl-phosphate glcnac-1-phosphate transerase Registry number: EC 2.7.8.15 Synonym: n-acetylglucosamine-1-phosphate transferase, dol-p-p-glcnac synthase, dolichol pathway enzyme I, udp-acetylglucosamine-dolichol phosphate acetylglucosamine-1-phosphate transferase, glcnac-dp-1-phosphotransferase, udp-n-acetyl-d-glucosamine-dolichyl-phosphate n-acetyl-d-glucosaminephosphotransferase, dolichol-p-dependent n-acetylglucosamine-1-phosphate transferase, alg7 gene product (26 Jun 1999) |
| UDP-GlcNAc-undecaprenyl phosphate N-acetylglucosaminyl 1-phosphate transferase | <enzyme> Catalyses transfer of n-acetylglucosamine 1-phosphate from udp-glcnac to undecaprenyl phosphate Registry number: EC 2.7.8.- Synonym: glcnac-p-p-und synthase, gpt enzyme (26 Jun 1999) |
| ATP citrate lyase | ATP citrate (pro-3S)-lyase |
| ATP citrate (pro-3S)-lyase | <enzyme> An enzyme that, in the presence of ATP and CoA, catalyses the cleavage of citrate to yield acetyl CoA, oxaloacetate, ADP, and orthophosphate. This reaction represents an important step in fatty acid biosynthesis. Chemical name: ATP:citrate oxaloacetate-lyase ((pro-S)-CH2COO(-)--acetyl-CoA) (ATP-dephosphorylating) Registry number: EC 4.1.3.8 Synonym: citrate cleavage enzyme. (12 Dec 1998) |
| bismuth ammonium citrate | Ammoniocitrate of bismuth; an intestinal astringent. (05 Mar 2000) |
| bismuth citrate | Used in the making of bismuth and ammonium citrate. (05 Mar 2000) |
| caffeine citrate | Citrated caffeine, a mixture of equal parts of caffeine and citric acid. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|